Cargando…
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures
An in silico chemical genomics approach is developed to predict drug repositioning (DR) candidates for three types of cancer: glioblastoma, lung cancer, and breast cancer. It is based on a recent large-scale dataset of ~20,000 drug-induced expression profiles in multiple cancer cell lines, which pro...
Autores principales: | Lee, Haeseung, Kang, Seungmin, Kim, Wankyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783079/ https://www.ncbi.nlm.nih.gov/pubmed/26954019 http://dx.doi.org/10.1371/journal.pone.0150460 |
Ejemplares similares
-
Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
por: Hong, Soon-Ki, et al.
Publicado: (2018) -
Comparison of Target Features for Predicting Drug-Target Interactions by Deep Neural Network Based on Large-Scale Drug-Induced Transcriptome Data
por: Lee, Hanbi, et al.
Publicado: (2019) -
Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015) -
Large-scale computational drug repositioning to find treatments for rare diseases
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2018) -
A Large-Scale Gene Expression Intensity-Based Similarity Metric for Drug Repositioning
por: Huang, Chen-Tsung, et al.
Publicado: (2018)